BGLAF (BioGaia AB) Dividend Payout Ratio: 0.00 (As of Mar. 2026)

What is BioGaia AB Dividend Payout Ratio?

BioGaia AB BGLAF 100 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates BGLAF with a GF Score™ of 100/100 and a GF Value™ of $13.05. The stock has 5 warning signs investors should review. Among 444 Drug Manufacturers companies, BioGaia AB ranks worse than 75% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. BioGaia AB's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.00.

The historical rank and industry rank for BioGaia AB's Dividend Payout Ratio or its related term are showing as below:

BGLAF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.24 Med: 0.38 Max: 0.73
Current: 0.58

During the past 13 years, the highest Dividend Payout Ratio of BioGaia AB was 0.73. The lowest was 0.24. And the median was 0.38.

BGLAF's Dividend Payout Ratio is ranked worse than
75% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.375 vs BGLAF: 0.58

As of today (2026-06-28), the Dividend Yield % of BioGaia AB is 1.43%.

During the past 13 years, the highest Trailing Annual Dividend Yield of BioGaia AB was 2.85%. The lowest was 0.55%. And the median was 1.03%.

BioGaia AB's Dividends per Share for the months ended in Mar. 2026 was $0.00.

During the past 12 months, BioGaia AB's average Dividends Per Share Growth Rate was 2.60% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 39.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 27.70% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 9.80% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of BioGaia AB was 66.40% per year. The lowest was -27.60% per year. And the median was 31.05% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

BioGaia AB (OTCPK:BGLAF) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

BioGaia AB Dividend Payout Ratio Related Terms

BioGaia AB Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for BioGaia AB's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB Dividend Payout Ratio Chart

BioGaia AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Dividend Payout Ratio

Get a 7-Day Free Trial

0.35

0.24

0.39

0.53

0.59

BioGaia AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividend Payout Ratio	Get a 7-Day Free Trial															0.00	2.24	0.00	0.00	0.00

BGLAF vs ZTS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioGaia AB Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Dividend Payout Ratio falls into.

Save Embed

100GF Score

BioGaia AB BGLAF

Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BioGaia AB Dividend Payout Ratio Calculation

BioGaia AB's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2025 )	/	EPS without NRI (A: Dec. 2025 )
	=	0.21	/	0.356
	=	0.59

BioGaia AB's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	EPS without NRI (Q: Mar. 2026 )
	=	0	/	0.084
	=	0.00

Frequently Asked Questions Learn more about Dividend Payout Ratio →

What does a Dividend Payout Ratio of 0.00 mean?

BioGaia AB (BGLAF) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on BioGaia AB and its competitors. Over the past decade, BioGaia AB's Dividend Payout Ratio has ranged from 0.24 to 0.73. According to the industry distribution chart, BioGaia AB ranks #333 out of 444 companies in the Drug Manufacturers industry, placing it in the top 75%.

Is BioGaia AB's Dividend Payout Ratio too high?

BioGaia AB's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 0.73. Based on the distribution chart, BioGaia AB ranks #333 out of 444 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, BioGaia AB has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.

How does BioGaia AB's Dividend Payout Ratio compare to ZTS?

According to the Drug Manufacturers industry distribution chart, BioGaia AB ranks #333 out of 444 companies for Dividend Payout Ratio. This places BioGaia AB in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, BioGaia AB's own Dividend Payout Ratio has ranged from 0.24 to 0.73 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividend Payout Ratio for a Drug Manufacturers company?

The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividend Payout Ratio mean?

A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on BioGaia AB and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioGaia AB's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BioGaia AB stock overvalued right now?

BioGaia AB (BGLAF) has a current Dividend Payout Ratio of 0.00. The stock's GF Value™ is $13.05, compared to a current price of $12.20 — trading 6.5% below its estimated fair value. The current Dividend Payout Ratio is 0.00. BioGaia AB's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividend Payout Ratio calculated?

Dividend Payout Ratio is calculated from a company's financial statements. For BioGaia AB (BGLAF), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioGaia AB (BGLAF) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued. The current stock price of $12.20 is trading 6.5% below its estimated GF Value™ of $13.05.

Key valuation signals for BGLAF:

Dividend Payout Ratio: 0.00
GF Value™: $13.05 vs. price of $12.20 (6.5% below fair value)
GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the BGLAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioGaia AB Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies OSTO:CRNO B OSTO:NANEXA OSTO:EQL OSTO:ORX OSTO:ENZY OSTO:CINPHA OSTO:MOB OSTO:DICOT OSTO:KLAR XSAT:ACUC XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Other Exchanges BIOG B:Sweden 0GTN:UK BGLA:Germany

Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website https://www.biogaiagroup.com

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).

100GF Score

Get the complete analysis for BGLAF

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.20

Price

$13.05

GF Value

View BGLAF Analysis

See Dividend Payout Ratio data for all stocks →